-
Circulating Butyrate Attenuates Cetuximab Efficacy in Colorectal Cancer Through EGFR and AMPK–Wip1 Signaling
21 Jan 2026 22:55 GMT
… Proliferation and Reduces Cetuximab Efficacy
Circulating butyrate … ’s correlation).
Discussion
Cetuximab remains an established targeted … interventions) can improve cetuximab efficacy while ensuring safety … mutant non-small-cell lung cancer. Front Oncol. 2022 …
-
Merck Healthcare Korea marks World Cancer Day with patient-centered campaign
09 Feb 2026 19:54 GMT
… -small cell lung cancer with confirmed MET exon 14 skipping, and Erbitux (cetuximab) for …
-
Enhancing NK Cell Activity in Colorectal Cancer with an Fc-Optimized Antibody Targeting CD276 (B7-H3)
09 Feb 2026 17:48 GMT
… mortality, surpassed by lung cancer.1 The considerable mortality … acute myeloid leukemia and lung cancer,31,34 underscoring its … , et al. Cetuximab monotherapy and cetuximab plus irinotecan in … against non-small cell lung cancer. Front Immunol. 2025 …
-
Prospects and Challenges of Chitosan-Based Drug Carriers for Anticancer Agents’ Delivery Against Lung Cancer: A Review
24 Oct 2025 14:10 GMT
… lung cancer into non-small cell lung cancer (NSCLC) and small cell lung cancer … of lung cancer.
Current treatment modalities for lung cancer include … CPT-NPs inhibited lung tumor growth by … N, Roberts CJ. Cetuximab-conjugated chitosan-pectinate (modified …
-
<![CDATA[Rx Road Map: Adagrasib With Cetuximab for KRAS G12C-Mutated mCRC]]>
03 Dec 2025 19:41 GMT
… KRAS G12C inhibitor, with cetuximab (Erbitux), an EGFR inhibitor, for … non–small cell lung cancer after systemic therapy … dosing prior to administering cetuximab.
Cetuximab can cause low … -mutated non-small cell lung cancer receiving adagrasib. Oncologist. …
-
Lung Cancer Drugs Shows Promise for Treatment-Resistant Melanoma
11 Jun 2025 19:07 GMT
… and lung cancers. The researchers tested two drugs from this class, Erbitux (cetuximab) and …
-
Investigational MK-1084 Demonstrates Antitumor Activity in Phase I Trial for Colorectal and Non-Small Cell Lung Cancers
31 May 2025 01:07 GMT
… CRC) and non-small cell lung cancer (NSCLC). Across both patient … and in combination with cetuximab with or without chemotherapy … with non-small cell lung cancer. Based on early evidence … metastatic non-small cell lung cancer.”
Upcoming KANDLELIT-012 trial …
-
Merck Announces MK-1084, an Investigational KRAS G12C Inhibitor, Shows Antitumor Activity in Phase 1 Trial of Patients With Advanced Colorectal Cancer and Non-Small Cell Lung Cancer Whose Tumors Harbor KRAS G12C Mutations
30 May 2025 12:21 GMT
… CRC) and non-small cell lung cancer (NSCLC). In patients with … as in combination with cetuximab with or without chemotherapy … test.
Non-Small Cell Lung Cancer
KEYTRUDA, in combination with … metastatic nonsquamous non-small cell lung cancer (NSCLC), with no …
-
Phase 1/2 Trial Investigating ATR-04 for EGFRi-Related Rashes in Lung Cancer
28 May 2025 22:23 GMT
… patients with non-small cell lung cancer, colorectal cancer and others, … , such as non-small cell lung cancer, colorectal cancer, pancreatic cancer, …
EGFR inhibitors — including drugs like Erbitux (cetuximab), Vectibix (panitumumab), Tarceva (erlotinib) …
-
Personalizing Lung Cancer Treatment Reduces Toxicity and Improves Cure Rates
08 May 2025 14:25 GMT
… population.3
New lung cancer treatment options have … NSCLC. Chemotherapy-free lung cancer treatment would be … effective.
Advancing Personalized Lung Cancer Treatment
Chemotherapy can cause … cetuximab for unresectable stage III non-small-cell lung cancer. …
About
© 1995-2026